NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting Nectin-4 in participants with advanced or metastatic urothelial carcinoma or other solid tumors Meeting Abstract
| Authors: | Gao, X.; Patnaik, A.; Lakhani, N. J.; Call, J. A.; Galsky, M. D.; Garmezy, B.; Wei, A. Z.; Carter, L.; Powles, T.; Siefker-Radtke, A. O.; O'Donnell, P. H.; Kitano, S.; Castellano, D.; Shinde, R.; Joshua, A. M.; Balbas, M.; Han, H.; Chang, A. E.; Baldini, C.; Iyer, G. |
| Abstract Title: | NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting Nectin-4 in participants with advanced or metastatic urothelial carcinoma or other solid tumors |
| Meeting Title: | 2025 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2025 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-02-10 |
| Language: | English |
| ACCESSION: | WOS:001454666200012 |
| DOI: | 10.1200/JCO.2025.43.5_suppl.TPS900 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS900 -- Source: Wos |
